Bapcha's Stocks. The best insights into Silicon Valley & bio/pharma stocks, companies and their management.

Everyone wants to find the next Cisco, the next Microsoft, the next ISRG. ISRG has carved out a niche in the prostate surgery market – with the key buzzwords being POTENCY and CONTINENCE – enough to scare any self-respecting man to cower at the thought of near-castration [yeah, that includes me]. Forget the robotic arms, ...